HUBS

HubSpot, Inc. NYSE

Technology ·Software - Application ·US · hubspot.com

$246.08

Mkt Cap $12.7B

52w Low $187.45 11.8% of range 52w High $682.57

50d MA $243.01 200d MA $372.17

P/E (TTM) 272.6x

EV/EBITDA 117.4x

P/B 6.1x

Debt/Equity 0.2x

ROE 2.2%

P/FCF 29.8x

RSI (14) —

ATR (14) —

Beta 1.44

50d MA $243.01

200d MA $372.17

Avg Volume 1.9M

About

HubSpot, Inc. provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific. The company's CRM platform includes marketing, sales, service, and content management systems, as well as integrated applications, such as search engine optimization, blogging, website content management, messaging, chatbots, social media, marketing aut…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 11, 2026	AMC	2.99	3.09	+3.3%	209.33	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%	—
Nov 5, 2025	AMC	2.59	2.66	+2.7%	464.71	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%	—
Aug 6, 2025	AMC	2.12	2.19	+3.3%	492.62	+5.5%	-6.2%	-8.7%	-14.6%	-14.0%	-11.1%	—
May 8, 2025	AMC	1.77	1.78	+0.6%	660.36	-7.0%	-8.7%	+0.3%	+1.8%	+1.5%	+0.6%	—
Feb 12, 2025	AMC	2.18	2.32	+6.4%	785.50	+6.5%	+4.4%	+3.4%	+2.3%	-1.9%	-4.8%	—
Nov 6, 2024	AMC	1.91	2.18	+14.1%	597.79	+5.7%	+7.8%	+9.8%	+13.9%	+17.3%	+17.1%	—
Aug 7, 2024	AMC	1.64	1.94	+18.3%	460.74	+6.4%	+3.4%	+2.6%	+1.9%	+5.2%	+5.1%	—
May 8, 2024	AMC	1.49	1.68	+12.8%	590.05	+5.9%	-0.5%	+1.3%	+1.3%	-0.1%	+4.1%	—
Feb 14, 2024	AMC	1.54	1.76	+14.3%	629.64	+2.3%	-3.3%	-2.6%	-5.4%	-6.4%	-4.7%	—
Nov 8, 2023	AMC	1.23	1.59	+29.3%	442.15	+5.2%	-6.1%	-3.0%	-2.4%	+3.0%	+5.9%	—
Aug 2, 2023	AMC	0.99	1.34	+35.4%	553.23	-7.0%	-11.4%	-12.6%	-10.7%	-12.5%	-11.8%	—
May 3, 2023	AMC	0.83	1.20	+44.6%	417.99	+8.0%	+7.4%	+6.3%	+6.4%	+7.1%	+10.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 21	BTIG	Maintains	Buy → Buy	—	$229.88	$230.72	+0.4%	+0.3%	+1.2%	-6.6%	-2.9%	-2.1%
Apr 20	Macquarie	Maintains	Outperform → Outperform	—	$222.49	$221.44	-0.5%	+3.3%	+3.6%	+4.6%	-3.5%	+0.4%
Apr 16	Canaccord Genuity	Maintains	Buy → Buy	—	$218.62	$228.78	+4.6%	+2.0%	+1.8%	+5.2%	+5.4%	+6.5%
Apr 16	RBC Capital	Maintains	Outperform → Outperform	—	$218.62	$228.78	+4.6%	+2.0%	+1.8%	+5.2%	+5.4%	+6.5%
Apr 14	Piper Sandler	Maintains	Overweight → Overweight	—	$205.28	$209.58	+2.1%	+0.6%	+6.5%	+8.6%	+8.4%	+12.0%
Apr 14	UBS	Maintains	Buy → Buy	—	$205.28	$209.58	+2.1%	+0.6%	+6.5%	+8.6%	+8.4%	+12.0%
Apr 2	Stifel	Maintains	Buy → Buy	—	$242.79	$240.00	-1.1%	+0.8%	+1.0%	-6.3%	-10.2%	-15.5%
Mar 3	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$263.60	$259.09	-1.7%	+4.5%	+5.7%	+10.6%	+12.5%	+8.8%
Feb 13	Citigroup	Maintains	Buy → Buy	—	$228.95	$235.91	+3.0%	+6.5%	+8.0%	+9.3%	+4.6%	+2.0%
Feb 13	Barclays	Maintains	Overweight → Overweight	—	$228.95	$235.91	+3.0%	+6.5%	+8.0%	+9.3%	+4.6%	+2.0%
Feb 12	RBC Capital	Maintains	Outperform → Outperform	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	BMO Capital	Maintains	Outperform → Outperform	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Mizuho	Maintains	Outperform → Outperform	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Piper Sandler	Maintains	Overweight → Overweight	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Needham	Maintains	Buy → Buy	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Wells Fargo	Maintains	Overweight → Overweight	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Jefferies	Maintains	Buy → Buy	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Truist	Maintains	Buy → Buy	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	UBS	Maintains	Buy → Buy	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	JP Morgan	Maintains	Overweight → Overweight	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Goldman Sachs	Maintains	Buy → Buy	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Macquarie	Maintains	Outperform → Outperform	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	BTIG	Maintains	Buy → Buy	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 12	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$209.33	$227.65	+8.8%	+9.4%	+16.5%	+18.1%	+19.5%	+14.4%
Feb 4	Oppenheimer	Maintains	Outperform → Outperform	—	$245.16	$241.05	-1.7%	-0.5%	-8.8%	-5.1%	-5.7%	-5.4%
Feb 4	Citigroup	Maintains	Buy → Buy	—	$245.16	$241.05	-1.7%	-0.5%	-8.8%	-5.1%	-5.7%	-5.4%
Feb 3	Piper Sandler	Maintains	Overweight → Overweight	—	$274.06	$263.43	-3.9%	-10.5%	-11.0%	-18.5%	-15.1%	-15.7%
Jan 28	Goldman Sachs	Maintains	Buy → Buy	—	$319.66	$325.86	+1.9%	-0.8%	-11.9%	-12.4%	-14.3%	-23.3%
Jan 28	UBS	Maintains	Buy → Buy	—	$319.66	$325.86	+1.9%	-0.8%	-11.9%	-12.4%	-14.3%	-23.3%
Jan 23	Stifel	Maintains	Buy → Buy	—	$319.50	$321.12	+0.5%	+1.0%	+3.0%	+0.1%	-0.7%	-11.9%
Jan 15	Morgan Stanley	Maintains	Overweight → Overweight	—	$345.30	$346.14	+0.2%	-4.7%	-9.7%	-11.7%	-12.4%	-7.5%
Jan 12	Barclays	Maintains	Overweight → Overweight	—	$371.56	$371.60	+0.0%	+1.2%	-3.4%	-7.1%	-11.4%	-16.1%
Nov 20	Argus	Maintains	Buy → Buy	—	$361.90	$370.38	+2.3%	-1.3%	-1.8%	-1.5%	+2.7%	-0.0%
Nov 10	Rothschild & Co	Downgrade	Buy → Neutral	—	$398.40	$394.96	-0.9%	-3.0%	-0.8%	-0.9%	-2.0%	-0.5%
Nov 7	Truist	Maintains	Buy → Buy	—	$394.95	$390.54	-1.1%	+0.9%	-2.2%	+0.0%	-0.1%	-1.1%
Nov 7	Goldman Sachs	Maintains	Buy → Buy	—	$394.95	$390.54	-1.1%	+0.9%	-2.2%	+0.0%	-0.1%	-1.1%
Nov 7	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$394.95	$390.54	-1.1%	+0.9%	-2.2%	+0.0%	-0.1%	-1.1%
Nov 6	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	BMO Capital	Maintains	Outperform → Outperform	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	Piper Sandler	Maintains	Overweight → Overweight	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	Oppenheimer	Maintains	Outperform → Outperform	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	Needham	Maintains	Buy → Buy	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	JP Morgan	Maintains	Overweight → Overweight	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	UBS	Maintains	Buy → Buy	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	Barclays	Maintains	Overweight → Overweight	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	BofA Securities	Maintains	Buy → Buy	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	Stifel	Maintains	Buy → Buy	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	Mizuho	Maintains	Outperform → Outperform	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%
Nov 6	Canaccord Genuity	Maintains	Buy → Buy	—	$464.71	$402.90	-13.3%	-15.0%	-14.3%	-16.9%	-15.0%	-15.1%

Recent Filings

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

Without seeing the specific executive change details in Exhibit 99.1, investors should await full disclosure, as leadership transitions at HubSpot could significantly impact strategy and near-term stock performance depending on the executive's role and replacement credentials.

Apr 1

8-K · 5.03 ! Medium

Unknown — 8-K 5.03: Amendment to Articles / Bylaws

HubSpot amended its bylaws, likely addressing governance, shareholder rights, or operational procedures; investors should review the actual amendment terms to assess any material changes to voting power or corporate structure.

Mar 11

8-K

HUBSPOT, INC. -- 8-K Filing

HubSpot delivered strong 2025 results with full-year revenue growth of 19% on an as-reported basis and 18% in constant currency, demonstrating consistent momentum for the customer platform company.

Feb 11

Data updated apr 25, 2026 2:19pm · Source: massive.com